{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T21:35:56Z","timestamp":1792445756604,"version":"4.5.0"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T00:00:00Z","timestamp":1758758400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003243","name":"Ministry of Health of the Czech Republic","doi-asserted-by":"publisher","award":["NU23\\u201303\\u201300401"],"award-info":[{"award-number":["NU23\\u201303\\u201300401"]}],"id":[{"id":"10.13039\/501100003243","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003243","name":"Ministry of Health of the Czech Republic","doi-asserted-by":"publisher","award":["00023736"],"award-info":[{"award-number":["00023736"]}],"id":[{"id":"10.13039\/501100003243","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.biopha.2025.118612","type":"journal-article","created":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T17:22:58Z","timestamp":1759339378000},"page":"118612","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Interferon signature predicts chemotherapy resistance in acute myeloid leukaemia"],"prefix":"10.1016","volume":"192","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0249-3972","authenticated-orcid":false,"given":"Ela","family":"Cerovska","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Kundrat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zdenek","family":"Krejcik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0021-3247","authenticated-orcid":false,"given":"Cyril","family":"Salek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9378-5956","authenticated-orcid":false,"given":"Jan","family":"Musil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eliska","family":"Cechova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michaela","family":"Dostalova Merkerova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monika","family":"Belickova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2967-8355","authenticated-orcid":false,"given":"Hana","family":"Remesova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.biopha.2025.118612_bib1","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1056\/NEJMra1406184","article-title":"Acute myeloid leukemia","volume":"373","author":"D\u00f6hner","year":"2015","journal-title":"N. Engl. J. Med."},{"issue":"12","key":"10.1016\/j.biopha.2025.118612_bib2","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1182\/blood.2022016867","article-title":"Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN","volume":"140","author":"D\u00f6hner","year":"2022","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.biopha.2025.118612_bib3","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1038\/nrc706","article-title":"Multidrug resistance in cancer: role of ATP-dependent transporters","volume":"2","author":"Gottesman","year":"2002","journal-title":"Nat. Rev. Cancer"},{"issue":"9","key":"10.1016\/j.biopha.2025.118612_bib4","doi-asserted-by":"crossref","DOI":"10.1007\/s12032-023-02138-y","article-title":"Cancer chemoresistance and its mechanisms: associated molecular factors and its regulatory role","volume":"40","author":"Kannampuzha","year":"2023","journal-title":"Med. Oncol."},{"issue":"1","key":"10.1016\/j.biopha.2025.118612_bib5","article-title":"Metascape provides a biologist-oriented resource for the analysis of systems-level datasets","volume":"10","author":"Zhou","year":"2019","journal-title":"Nat. Commun."},{"issue":"11","key":"10.1016\/j.biopha.2025.118612_bib6","doi-asserted-by":"crossref","first-page":"7284","DOI":"10.21037\/tcr-20-3177","article-title":"Analyzing the key gene expression and prognostics values for acute myeloid leukemia","volume":"9","author":"Shi","year":"2020","journal-title":"Transl. Cancer Res."},{"issue":"8","key":"10.1016\/j.biopha.2025.118612_bib7","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0043185","article-title":"Overexpression of MN1 confers resistance to chemotherapy, accelerates leukemia onset, and suppresses p53 and bim induction","volume":"7","author":"Pardee","year":"2012","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.biopha.2025.118612_bib8","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1182\/blood-2009-06-227363","article-title":"SETBP1 overexpression is a novel leukemogenic mechanism that predicts adverse outcome in elderly patients with acute myeloid leukemia","volume":"115","author":"Crist\u00f3bal","year":"2010","journal-title":"Blood"},{"issue":"16","key":"10.1016\/j.biopha.2025.118612_bib9","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1056\/NEJMoa031046","article-title":"Use of Gene-Expression profiling to identify prognostic subclasses in adult acute myeloid leukemia","volume":"350","author":"Bullinger","year":"2004","journal-title":"N. Engl. J. Med."},{"issue":"5","key":"10.1016\/j.biopha.2025.118612_bib10","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1182\/blood-2006-02-005538","article-title":"Independent confirmation of a prognostic gene-expression signature in adult acute myeloid leukemia with a normal karyotype: a cancer and leukemia group b study","volume":"108","author":"Radmacher","year":"2006","journal-title":"Blood"},{"issue":"10","key":"10.1016\/j.biopha.2025.118612_bib11","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1038\/leu.2017.48","article-title":"Validation of risk stratification models in acute myeloid leukemia using sequencing-based molecular profiling","volume":"31","author":"Wang","year":"2017","journal-title":"Leukemia"},{"issue":"10","key":"10.1016\/j.biopha.2025.118612_bib12","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1093\/jnci\/djy021","article-title":"Development and validation of a novel RNA Sequencing\u2013Based prognostic score for acute myeloid leukemia","volume":"110","author":"Wang","year":"2018","journal-title":"J. Natl. Cancer Inst."},{"issue":"6","key":"10.1016\/j.biopha.2025.118612_bib13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41408-020-0332-3","article-title":"Integrated transcriptomic and genomic analysis improves prediction of complete remission and survival in elderly patients with acute myeloid leukemia","volume":"10","author":"\u00d6sterroos","year":"2020","journal-title":"Blood Cancer J."},{"issue":"10","key":"10.1016\/j.biopha.2025.118612_bib14","doi-asserted-by":"crossref","first-page":"2799","DOI":"10.1038\/s41375-021-01338-7","article-title":"Single cell RNA sequencing of AML initiating cells reveals RNA-based evolution during disease progression","volume":"35","author":"Stetson","year":"2021","journal-title":"Leukemia"},{"issue":"1","key":"10.1016\/j.biopha.2025.118612_bib15","first-page":"1","article-title":"Early response evaluation by single cell signaling profiling in acute myeloid leukemia","volume":"14","author":"Tislevoll","year":"2023","journal-title":"Nat. Commun."},{"issue":"2","key":"10.1016\/j.biopha.2025.118612_bib16","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/bph.16149","article-title":"Targeting integrins in drug-resistant acute myeloid leukaemia","volume":"181","author":"Ogana","year":"2024","journal-title":"Br. J. Pharm."},{"key":"10.1016\/j.biopha.2025.118612_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2020.103164","article-title":"Immune evasion mechanisms in acute myeloid leukemia: a focus on immune checkpoint pathways","volume":"157","author":"Taghiloo","year":"2021","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"10.1016\/j.biopha.2025.118612_bib18","doi-asserted-by":"crossref","first-page":"1018154","DOI":"10.3389\/fonc.2022.1018154","article-title":"Fatty acid metabolism predicts prognosis and NK cell immunosurveillance of acute myeloid leukemia patients","volume":"12","author":"Ye","year":"2022","journal-title":"Front. Oncol."},{"issue":"10","key":"10.1016\/j.biopha.2025.118612_bib19","doi-asserted-by":"crossref","first-page":"5698","DOI":"10.1093\/nar\/gkae233","article-title":"ARID1A regulates DNA repair through chromatin organization and its deficiency triggers DNA damage-mediated anti-tumor immune response","volume":"52","author":"Bakr","year":"2024","journal-title":"Nucleic Acids Res."},{"issue":"1","key":"10.1016\/j.biopha.2025.118612_bib20","first-page":"1","article-title":"Cyclin-dependent protein kinases and cell cycle regulation in biology and disease","volume":"10","author":"Pellarin","year":"2025","journal-title":"Signal Transduc Target Ther."},{"issue":"5","key":"10.1016\/j.biopha.2025.118612_bib21","doi-asserted-by":"crossref","DOI":"10.3390\/biom11050622","article-title":"Functional interfaces, biological pathways, and regulations of Interferon-Related DNA damage resistance signature (IRDS) genes","volume":"11","author":"Padariya","year":"2021","journal-title":"Biomolecules"},{"issue":"47","key":"10.1016\/j.biopha.2025.118612_bib22","doi-asserted-by":"crossref","first-page":"18490","DOI":"10.1073\/pnas.0809242105","article-title":"An interferon-related gene signature for DNA damage resistance is a predictive marker for chemotherapy and radiation for breast cancer","volume":"105","author":"Weichselbaum","year":"2008","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"3","key":"10.1016\/j.biopha.2025.118612_bib23","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.ccell.2018.05.013","article-title":"Cytosolic DNA sensing in organismal tumor control","volume":"34","author":"Vanpouille-Box","year":"2018","journal-title":"Cancer Cell"},{"issue":"5","key":"10.1016\/j.biopha.2025.118612_bib24","doi-asserted-by":"crossref","first-page":"3306","DOI":"10.18632\/oncotarget.2494","article-title":"Overexpression of IFN-induced protein with tetratricopeptide repeats 3 (IFIT3) in pancreatic cancer: cellular \u201cpseudoinflammation\u201d contributing to an aggressive phenotype","volume":"6","author":"Niess","year":"2015","journal-title":"Oncotarget"},{"issue":"13_ement","key":"10.1016\/j.biopha.2025.118612_bib25","article-title":"Abstract 2896: STAT1 dependent interferon-related DNA damage resistance signature (IRDS) as a survival mechanism in castrate resistant prostate cancer (CRPC)","volume":"77","author":"Agarwal","year":"2017","journal-title":"Cancer Res."},{"issue":"6","key":"10.1016\/j.biopha.2025.118612_bib26","doi-asserted-by":"crossref","DOI":"10.1038\/s41419-019-1669-z","article-title":"The roles and mechanism of IFIT5 in bladder cancer epithelial-mesenchymal transition and progression","volume":"10","author":"Huang","year":"2019","journal-title":"Cell Death Dis."},{"issue":"1","key":"10.1016\/j.biopha.2025.118612_bib27","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1159\/000486219","article-title":"Decreased IFIT2 expression promotes gastric cancer progression and predicts poor prognosis of the patients","volume":"45","author":"Chen","year":"2018","journal-title":"Cell Physiol. Biochem."},{"issue":"1","key":"10.1016\/j.biopha.2025.118612_bib28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-018-37294-z","article-title":"STAT3 is activated in multicellular spheroids of colon carcinoma cells and mediates expression of IRF9 and interferon stimulated genes","volume":"9","author":"Edsb\u00e4cker","year":"2019","journal-title":"Sci. Rep."},{"issue":"5","key":"10.1016\/j.biopha.2025.118612_bib29","doi-asserted-by":"crossref","first-page":"2462","DOI":"10.1128\/JVI.02744-14","article-title":"Interferon-induced ifit proteins: their role in viral pathogenesis","volume":"89","author":"Fensterl","year":"2015","journal-title":"J. Virol."},{"issue":"18","key":"10.1016\/j.biopha.2025.118612_bib30","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00297-20","article-title":"Interferon-Induced protein 44 and Interferon-Induced protein 44-Like restrict replication of respiratory syncytial virus","volume":"94","author":"Busse","year":"2020","journal-title":"J. Virol."},{"issue":"21","key":"10.1016\/j.biopha.2025.118612_bib31","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.01159-19","article-title":"Novel functions of IFI44L as a feedback regulator of host antiviral responses","volume":"93","author":"DeDiego","year":"2019","journal-title":"J. Virol."},{"key":"10.1016\/j.biopha.2025.118612_bib32","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/5599408","article-title":"IFI44L as a forward regulator enhancing host antituberculosis responses","volume":"2021","author":"Jiang","year":"2021","journal-title":"J. Immunol. Res."},{"issue":"1","key":"10.1016\/j.biopha.2025.118612_bib33","doi-asserted-by":"crossref","DOI":"10.1186\/s12920-023-01735-0","article-title":"The diagnostic\/prognostic roles and biological function of the IFIT family members in acute myeloid leukemia","volume":"16","author":"Zhao","year":"2023","journal-title":"BMC Med. Genom."},{"key":"10.1016\/j.biopha.2025.118612_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellsig.2025.111652","article-title":"STAT1 inhibition promotes oxidative stress to sustain leukemia stem cell maintenance","volume":"130","author":"Han","year":"2025","journal-title":"Cell Signal"},{"key":"10.1016\/j.biopha.2025.118612_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.blre.2019.100634","article-title":"JAKs to STATs: a tantalizing therapeutic target in acute myeloid leukemia","volume":"40","author":"Venugopal","year":"2020","journal-title":"Blood Rev."},{"issue":"1","key":"10.1016\/j.biopha.2025.118612_bib36","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12929-022-00803-4","article-title":"A chemical probe inhibitor targeting STAT1 restricts cancer stem cell traits and angiogenesis in colorectal cancer","volume":"29","author":"Chou","year":"2022","journal-title":"J. Biomed. Sci."},{"key":"10.1016\/j.biopha.2025.118612_bib37","article-title":"The complementary roles of STAT3 and STAT1 in cancer biology: insights into tumor pathogenesis and therapeutic strategies","volume":"14","author":"Wang","year":"2023","journal-title":"Front. Immunol."},{"issue":"3","key":"10.1016\/j.biopha.2025.118612_bib38","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1182\/blood-2009-11-254441","article-title":"Refinement of cytogenetic classification in acute myeloid leukemia: determination of prognostic significance of rare recurring chromosomal abnormalities among 5876 younger adult patients treated in the United Kingdom medical research council trials","volume":"116","author":"Grimwade","year":"2010","journal-title":"Blood"}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332225008066?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332225008066?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T00:42:08Z","timestamp":1775781728000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332225008066"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":38,"alternative-id":["S0753332225008066"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2025.118612","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Interferon signature predicts chemotherapy resistance in acute myeloid leukaemia","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2025.118612","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"118612"}}